Wockhardt

{
  "main_header": {
    "sid": 256229,
    "name": "Wockhardt",
    "stock_name": "Wockhardt",
    "full_name": "Wockhardt Ltd",
    "name_url": "stocks-analysis/wockhardt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,398.40",
    "chg": 2.5,
    "chgp": "0.18%",
    "dir": 1,
    "prev_price": "1,395.90",
    "mcapval": "22,391.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532300,
    "symbol": "WOCKPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE049B01025",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "2.5 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/wockhardt-256229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Wockhardt Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-wockhardt-ltd-3823086",
        "imagepath": "",
        "date": "2026-02-05 23:16:58",
        "description": "The next results date for Wockhardt Ltd is scheduled for 10 February 2026...."
      },
      {
        "title": "Wockhardt Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/wockhardt-ltd-is-rated-sell-3818003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WockhardtLtd_mojoScore_3818003.png",
        "date": "2026-02-03 10:10:04",
        "description": "Wockhardt Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Wockhardt Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3817515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/WockhardtLtd_gapup_3817515.png",
        "date": "2026-02-03 09:34:29",
        "description": "Wockhardt Ltd witnessed a significant gap up at the opening bell on 3 Feb 2026, surging by 5.98% compared to its previous close. This strong start underscores a positive market sentiment towards the pharmaceutical company, which outperformed its sector and broader market indices during the day."
      },
      {
        "title": "Wockhardt Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/wockhardt-ltd-is-rated-sell-3801524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WockhardtLtd_mojoScore_3801524.png",
        "date": "2026-01-23 10:10:03",
        "description": "Wockhardt Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Wockhardt Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/wockhardt-ltd-is-rated-sell-3789839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WockhardtLtd_mojoScore_3789839.png",
        "date": "2026-01-12 10:10:03",
        "description": "Wockhardt Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Wockhardt Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-3789181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WockhardtLtd_technicaldot_3789181.png",
        "date": "2026-01-12 08:00:45",
        "description": "Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent data indicating a transition from a mildly bullish trend to a sideways movement. Despite some positive weekly signals, monthly indicators suggest caution, reflecting a complex technical landscape for investors to navigate."
      },
      {
        "title": "Wockhardt Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-ltd-technical-momentum-shifts-amid-mixed-market-signals-3783866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WockhardtLtd_technicaldot_3783866.png",
        "date": "2026-01-07 08:04:02",
        "description": "Wockhardt Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the weekly charts, despite mixed signals from key technical indicators. The stock’s recent price action, combined with evolving momentum oscillators and moving averages, paints a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Wockhardt Ltd’s 1.74% Weekly Decline: Mixed Technical Signals and Earnings Drive Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-ltds-174-weekly-decline-mixed-technical-signals-and-earnings-drive-volatility-3780219",
        "imagepath": "",
        "date": "2026-01-04 15:25:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Dec 2025:</strong> Stock opens at ₹1,424.15, declines 0.76%</p>\n                    <p><strong>30 Dec 2025:</strong> Technical momentum shifts to mildly bearish, stock falls 3.21%</p>\n                    <p><strong>31 Dec 2025:</strong> Stock surges 4.89% amid rating upgrade to Hold</p>\n                    <p><strong>1 Jan 2026:</strong> Technical momentum shifts to mildly bullish, stock closes at ₹1,445.90</p>\n                    <p><strong>2 Jan 2026:</strong> Momentum shifts sideways, stock declines 0.83%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value..."
      },
      {
        "title": "Wockhardt Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/wockhardt-ltd-technical-momentum-shifts-amid-mixed-market-signals-3778078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/WockhardtLtd_technicaldot_3778078.png",
        "date": "2026-01-02 08:02:15",
        "description": "Wockhardt Ltd has experienced a notable shift in its technical momentum as it transitions from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages and a modest decline in share price, the stock’s weekly and monthly signals present a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 393,
    "sid": "256229",
    "stock_news_url": "https://www.marketsmojo.com/news/wockhardt-256229"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited (The Company)",
      "datetime": "04-Feb-2026",
      "details": "Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 10th February 2026 inter alia to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "03-Feb-2026",
      "details": "In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform you that Dr. Sanjeev Kumar Sharma President- Manufacturing Quality & R&D designated as Senior Management Personnel (SMP) of the Company has tendered his resignation from the services of the Company effective from close of business hours of 2nd February 2026 due to personal reasons and consequently shall cease to be SMP of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "27-Jan-2026",
      "details": "Pursuant to Regulation 30 0f Listing Regulations please find enclosed Press Release- Wockhardts Fifth Novel Antibiotic Foviscu (WCK 4282) Matches Gold Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance.:",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "10 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has declared <strong>200%</strong> dividend, ex-date: 17 Nov 16",
          "dt": "2016-11-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has announced <strong>3:10</strong> rights issue, ex-date: 08 Mar 22",
          "dt": "2022-03-08",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Wockhardt Ltd?

2026-02-05 23:16:58

The next results date for Wockhardt Ltd is scheduled for 10 February 2026....

Read full news article

Wockhardt Ltd is Rated Sell

2026-02-03 10:10:04

Wockhardt Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 January 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with the most up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Wockhardt Ltd Opens with Strong Gap Up, Reflecting Positive Market Sentiment

2026-02-03 09:34:29

Wockhardt Ltd witnessed a significant gap up at the opening bell on 3 Feb 2026, surging by 5.98% compared to its previous close. This strong start underscores a positive market sentiment towards the pharmaceutical company, which outperformed its sector and broader market indices during the day.

Read full news article

Wockhardt Ltd is Rated Sell

2026-01-23 10:10:03

Wockhardt Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Wockhardt Ltd is Rated Sell

2026-01-12 10:10:03

Wockhardt Ltd is rated Sell by MarketsMOJO, with this rating last updated on 05 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Wockhardt Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-12 08:00:45

Wockhardt Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent data indicating a transition from a mildly bullish trend to a sideways movement. Despite some positive weekly signals, monthly indicators suggest caution, reflecting a complex technical landscape for investors to navigate.

Read full news article

Wockhardt Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-07 08:04:02

Wockhardt Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend on the weekly charts, despite mixed signals from key technical indicators. The stock’s recent price action, combined with evolving momentum oscillators and moving averages, paints a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Wockhardt Ltd’s 1.74% Weekly Decline: Mixed Technical Signals and Earnings Drive Volatility

2026-01-04 15:25:00

Key Events This Week

29 Dec 2025: Stock opens at ₹1,424.15, declines 0.76%

30 Dec 2025: Technical momentum shifts to mildly bearish, stock falls 3.21%

31 Dec 2025: Stock surges 4.89% amid rating upgrade to Hold

1 Jan 2026: Technical momentum shifts to mildly bullish, stock closes at ₹1,445.90

2 Jan 2026: Momentum shifts sideways, stock declines 0.83%

Week Open

Read full news article

Wockhardt Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-02 08:02:15

Wockhardt Ltd has experienced a notable shift in its technical momentum as it transitions from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages and a modest decline in share price, the stock’s weekly and monthly signals present a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News